An open-label study of olanzapine in the first episode of schizophrenia in adolescents

被引：0
|
作者：
Dabokowska, M [1 ]
机构：
[1] Med Acad, Dept Psychiat, Bydgoszcz, Poland
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：115S / 115S
页数：1
相关论文
共 50 条
  • [41] Colchicine Administered in the First Episode of Acute Idiopathic Pericarditis: A Randomized Multicenter Open-label Study
    Sambola, Antonia
    Roca Luque, Ivo
    Merce, Jordi
    Alguersuari, Joan
    Francisco-Pascual, Jaume
    Garcia-Dorado, David
    Sagrista-Sauleda, Jaume
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (09): : 709 - 716
  • [42] A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder
    Frazier, JA
    Biederman, J
    Tohen, M
    Feldman, PD
    Jacobs, TG
    Toma, V
    Rater, MA
    Tarazi, RA
    Kim, GS
    Garfield, SB
    Sohma, M
    Gonzalez-Heydrich, J
    Risser, RC
    Nowlin, ZM
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (03) : 239 - 250
  • [43] Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension
    Tohen, Mauricio
    Kryzhanovskaya, Ludmila
    Carlson, Gabrielle
    DelBello, Melissa
    Wozniak, Janet
    Kowatch, Robert
    Wagner, Karen
    Findling, Robert
    Lin, Daniel
    Robertson-Plouch, Carol
    Xu, Wen
    Dittman, Ralf
    Biederman, Joe
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 882 - 882
  • [44] AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA - REPLY
    OYEWUMI, LK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1995, 20 (03): : 240 - 240
  • [45] Effects of Switching from Olanzapine to Aripiprazole on the Metabolic Profiles of Patients with Schizophrenia and Metabolic Syndrome: An Open-label Study
    不详
    INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S25 - S26
  • [46] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Yasukawa, Rei
    Yasuda, Hideaki
    Hayashida, Maiko
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (05) : 287 - 292
  • [47] Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension
    Tohen, Mauricio
    Kryzhanovskaya, Ludmila
    Carlson, Gabrielle
    DelBello, Melissa
    Wozniak, Janet
    Kowatch, Robert
    Wagner, Karen
    Findling, Robert
    Lin, Daniel
    Robertson-Plouch, Carol
    Xu, Wen
    Dittmann, Ralf
    Biederman, Joe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S215
  • [48] Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders
    Handen, Benjamin L.
    Hardan, Antonio Y.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (08): : 928 - 935
  • [49] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 91S - 91S
  • [50] FIRST CLINICAL-EXPERIENCE WITH OLANZAPINE (LY-170053) - RESULTS OF AN OPEN-LABEL SAFETY AND DOSE-RANGING STUDY IN PATIENTS WITH SCHIZOPHRENIA
    BALDWIN, DS
    MONTGOMERY, SA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (04) : 239 - 244
12345